BR112017013238A2 - bacteriófago esc-cop-1 de e. coli do tipo f18 produtora de toxina shiga inovador e uso do mesmo para a inibição de proliferação de e. coli do tipo f18 produtora de toxina shiga - Google Patents

bacteriófago esc-cop-1 de e. coli do tipo f18 produtora de toxina shiga inovador e uso do mesmo para a inibição de proliferação de e. coli do tipo f18 produtora de toxina shiga

Info

Publication number
BR112017013238A2
BR112017013238A2 BR112017013238A BR112017013238A BR112017013238A2 BR 112017013238 A2 BR112017013238 A2 BR 112017013238A2 BR 112017013238 A BR112017013238 A BR 112017013238A BR 112017013238 A BR112017013238 A BR 112017013238A BR 112017013238 A2 BR112017013238 A2 BR 112017013238A2
Authority
BR
Brazil
Prior art keywords
coli
shiga toxin
producing
cop
innovative
Prior art date
Application number
BR112017013238A
Other languages
English (en)
Inventor
Soo Youn Jun
Sang Hyeon Kang
Byung Kuk Kim
Hyoun Rok Paik
Suk Hwang; Park
Jee Soo Son
Seong Jun Yoon
Original Assignee
Intron Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intron Biotechnology Inc filed Critical Intron Biotechnology Inc
Publication of BR112017013238A2 publication Critical patent/BR112017013238A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00—Biological treatment of water, waste water, or sewage
    • C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00—Specific treatment goals
    • C02F2303/04—Disinfection
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2305/00—Use of specific compounds during water treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Water Supply & Treatment (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

resumo bacteriófago esc-cop-1 de e. coli do tipo f18 produtora de toxina shiga inovador e uso do mesmo para a inibição de proliferação de e. coli do tipo f18 produtora de toxina shiga a presente invenção refere-se a um bacteriófago esc-cop-1 de myoviridae que é isolado da natureza e pode exterminar especificamente as cepas de e. coli do tipo f18 produtora de toxina shiga, que tem um genoma representado pela sequência de nucleotídeos de seq. id. no: 1 (no de acesso: kctc 12662bp), e um método de prevenção e tratamento das infecções por e. coli do tipo 18 produtora de toxina shiga com o uso da composição que compreende o dito bacteriófago como um ingrediente ativo.
BR112017013238A 2014-12-30 2015-12-28 bacteriófago esc-cop-1 de e. coli do tipo f18 produtora de toxina shiga inovador e uso do mesmo para a inibição de proliferação de e. coli do tipo f18 produtora de toxina shiga BR112017013238A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140192983A KR101649851B1 (ko) 2014-12-30 2014-12-30 신규한 시가독소생산 F18형 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도
PCT/KR2015/014331 WO2016108541A1 (ko) 2014-12-30 2015-12-28 신규한 시가독소생산 F18형 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도

Publications (1)

Publication Number Publication Date
BR112017013238A2 true BR112017013238A2 (pt) 2018-08-07

Family

ID=56284613

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017013238A BR112017013238A2 (pt) 2014-12-30 2015-12-28 bacteriófago esc-cop-1 de e. coli do tipo f18 produtora de toxina shiga inovador e uso do mesmo para a inibição de proliferação de e. coli do tipo f18 produtora de toxina shiga

Country Status (8)

Country Link
US (1) US10265355B2 (pt)
KR (1) KR101649851B1 (pt)
CN (1) CN107208068B (pt)
BR (1) BR112017013238A2 (pt)
CO (1) CO2017006495A2 (pt)
MX (1) MX2017008563A (pt)
RU (1) RU2662985C1 (pt)
WO (1) WO2016108541A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101761573B1 (ko) * 2014-12-29 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장출혈성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-1 및 이의 장출혈성 대장균 증식 억제 용도
KR101649851B1 (ko) * 2014-12-30 2016-08-30 주식회사 인트론바이오테크놀로지 신규한 시가독소생산 F18형 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도
KR101761578B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장병원성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-2 및 이의 장병원성 대장균 증식 억제 용도
KR101761581B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장침입성 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-4 및 이의 장침입성 대장균 증식 억제 용도
US11058131B2 (en) 2015-04-16 2021-07-13 Kennesaw State University Research And Service Foundation, Inc. Escherichia coli O157:H7 bacteriophage Φ241
KR20180061774A (ko) * 2016-11-30 2018-06-08 주식회사 인트론바이오테크놀로지 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-7 및 이의 병원성 대장균 증식 억제 용도
KR101796642B1 (ko) 2016-11-30 2017-11-10 주식회사 인트론바이오테크놀로지 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-9 및 이의 병원성 대장균 증식 억제 용도
CN108906654B (zh) * 2018-05-15 2019-12-20 天津英创汇智汽车技术有限公司 Esc产品检测装置及方法
KR102073095B1 (ko) * 2018-07-11 2020-02-04 주식회사 인트론바이오테크놀로지 대장균 박테리오파지 Esc-COP-14 및 이의 병원성 대장균 증식 억제 용도
CN110129279B (zh) * 2019-04-24 2022-02-18 昆明理工大学 一种粪肠球菌噬菌体及其分离、纯化、富集和应用
CN111481574B (zh) * 2020-04-17 2023-03-14 吉林省农业科学院 一种用于治疗仔猪腹泻的组合型噬菌体制剂

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002366854A1 (en) 2001-12-13 2003-07-09 Societe Des Produits Nestle S.A. Isolated phages and their use in food or pet food products
KR100781669B1 (ko) * 2006-06-20 2007-12-03 주식회사 인트론바이오테크놀로지 황색포도상구균 특이적 사멸능을 갖는 박테리오파지
WO2008108989A2 (en) * 2007-03-02 2008-09-12 Danisco A/S Cultures with improved phage resistance
KR101016918B1 (ko) * 2009-01-08 2011-02-25 주식회사 인트론바이오테크놀로지 박테리아 특이적 넓은 항균 활성을 갖는 신규한 리신 단백질
US8846368B2 (en) 2009-09-03 2014-09-30 Cj Cheiljedang Corporation Bacteriophage and antibacterial composition comprising the same
KR101101376B1 (ko) 2009-10-16 2012-01-02 경희대학교 산학협력단 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지
CN101724607B (zh) * 2009-12-18 2012-05-09 江苏省农业科学院 一种产肠毒素性大肠杆菌的噬菌体ek99-c及其应用
AU2011220736C1 (en) * 2010-02-24 2014-12-18 The Broad Institute, Inc Methods of diagnosing infectious disease pathogens and their drug sensitivity
KR101275263B1 (ko) 2011-04-01 2013-06-14 서울대학교산학협력단 조류 병원성 대장균 특이 박테리오파지 및 이를 포함하는 항균 조성물
US20130011369A1 (en) * 2011-07-05 2013-01-10 Intron Biotechnology, Inc. Method for Prevention and Treatment of Salmonella Infection
KR101291052B1 (ko) * 2011-09-09 2013-08-01 주식회사 인트론바이오테크놀로지 살모넬라 티피무륨 감염을 방지 및 처치하는 방법
BR112014007394A2 (pt) * 2011-09-28 2018-08-28 Du Pont método para detectar a presença de bactérias, polinucleotídeo isolado, kit e comprimido reagente
KR101260645B1 (ko) 2011-11-14 2013-05-03 씨제이제일제당 (주) 대장균 특이적 사멸능을 나타내는 신규 분리된 박테리오파지 및 이를 포함하는 항균 조성물
US9504721B2 (en) * 2012-06-04 2016-11-29 Ctc Bio, Inc. Bacteriophage and its use for preventing proliferation of pathogenic bacteria
KR20140140698A (ko) * 2013-05-30 2014-12-10 한국외국어대학교 연구산학협력단 에세리키아 콜라이의 박테리오파아지 및 그 용도
KR101581654B1 (ko) * 2013-06-27 2015-12-31 주식회사 인트론바이오테크놀로지 K99형 대장균 감염을 방지 및 처치하는 방법
KR101590108B1 (ko) 2014-04-10 2016-01-29 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
KR101591795B1 (ko) 2014-04-15 2016-02-04 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
KR101591793B1 (ko) 2014-04-15 2016-02-04 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
KR101592177B1 (ko) * 2014-05-07 2016-02-05 주식회사 인트론바이오테크놀로지 대장균에 대한 광범위 항균 활성을 갖는 박테리오파지를 활용한 대장균 감염을 방지 및 처치하는 방법
KR101649849B1 (ko) * 2014-12-29 2016-08-22 주식회사 인트론바이오테크놀로지 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Ｃｌｏ-ＰＥＰ-1 및 이의 클로스트리디움 퍼프린젠스 증식 억제 용도
KR101761573B1 (ko) * 2014-12-29 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장출혈성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-1 및 이의 장출혈성 대장균 증식 억제 용도
KR101649851B1 (ko) * 2014-12-30 2016-08-30 주식회사 인트론바이오테크놀로지 신규한 시가독소생산 F18형 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도
KR101761581B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장침입성 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-4 및 이의 장침입성 대장균 증식 억제 용도
KR101761578B1 (ko) * 2014-12-30 2017-07-26 주식회사 인트론바이오테크놀로지 신규한 장병원성 대장균 박테리오파지 Ｅｓｃ-ＣＨＰ-2 및 이의 장병원성 대장균 증식 억제 용도
KR101676621B1 (ko) 2015-01-16 2016-11-16 주식회사 인트론바이오테크놀로지 신규한 락토코커스 가르비에 박테리오파지 Ｌａｃ-ＧＡＰ-1 및 이의 락토코커스 가르비에 균 증식 억제 용도
KR101679548B1 (ko) * 2015-01-28 2016-12-06 주식회사 인트론바이오테크놀로지 신규한 락토바실러스 브레비스 박테리오파지 Ｌａｃ-ＢＲＰ-1 및 이의 락토바실러스 브레비스 균 증식 억제 용도
KR101679549B1 (ko) * 2015-01-29 2016-12-06 주식회사 인트론바이오테크놀로지 신규한 락토바실러스 플랜타룸 박테리오파지 Ｌａｃ-ＰＬＰ-1 및 이의 락토바실러스 플랜타룸 균 증식 억제 용도
KR101699245B1 (ko) 2015-12-21 2017-02-13 주식회사 인트론바이오테크놀로지 신규한 파스튜렐라 멀토시다 박테리오파지 Ｐａｓ-ＭＵＰ-1 및 이의 파스튜렐라 멀토시다 균 증식 억제 용도
US10357522B2 (en) 2016-06-22 2019-07-23 The United States Of America As Represented By The Secretary Of The Navy Bacteriophage compositions and methods of selection of components against specific bacteria
KR20180061774A (ko) * 2016-11-30 2018-06-08 주식회사 인트론바이오테크놀로지 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-7 및 이의 병원성 대장균 증식 억제 용도

Also Published As

Publication number Publication date
RU2662985C1 (ru) 2018-07-31
KR20160080576A (ko) 2016-07-08
US20170340686A1 (en) 2017-11-30
US10265355B2 (en) 2019-04-23
KR101649851B1 (ko) 2016-08-30
CN107208068A (zh) 2017-09-26
MX2017008563A (es) 2017-10-26
WO2016108541A1 (ko) 2016-07-07
CO2017006495A2 (es) 2017-09-20
CN107208068B (zh) 2021-04-20

Similar Documents

Publication Publication Date Title
BR112017013238A2 (pt) bacteriófago esc-cop-1 de e. coli do tipo f18 produtora de toxina shiga inovador e uso do mesmo para a inibição de proliferação de e. coli do tipo f18 produtora de toxina shiga
BR112017013233A2 (pt) bacteriófago clo-pep-1 de clostridium perfringens inovador e uso do mesmo para a inibição de proliferação de clostridium perfringens
BR112017013245A2 (pt) bacteriófago esc-cop-4 de e. coli enteroinvasiva inovador e uso do mesmo para a inibição de proliferação de e. coli enteroinvasiva
BR112018012044A2 (pt) bacteriófago pas-mup-1 de pasteurella multocida inovador e uso do mesmo para inibir a proliferação de pasteurella multocida
MX2020002727A (es) Nuevo uso para tratamiento de infecciones por clostridium difficile.
CO2019010062A2 (es) Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens
MX2019004611A (es) Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas.
MX2016014807A (es) Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados.
BR112018003123A2 (pt) composição, enema, cepa isolada, método para tratamento e/ou prevenção de uma condição gastrointestinal, e, uso de uma composição, de um enema ou de uma ou mais de uma cepa bacteriana isolada
WO2017147130A3 (en) Direct fed microbial for prevention of shrimp disease
PH12016501988A1 (en) Antibacterial compounds
PH12016501999A1 (en) Novel bacteriophage and composition containing same
WO2019235782A8 (ko) 신규한 스트렙토코커스 수이스 박테리오파지 str-sup-2 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
MX2017016401A (es) Composiciones inmunogenas.
CO2020010533A2 (es) Novedoso bacteriófago de salmonella heidelberg sal-hep-1 y su uso para inhibir el crecimiento de las bacterias de salmonella heidelberg
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
WO2011155727A3 (ko) 살모넬라 콜레라수이스 또는 살모넬라 두블린 감염을 방지 및 처치하는 방법
BR112016015875A2 (pt) Elementos intensificadores de cpmv
WO2018101595A3 (ko) 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-9 및 이의 병원성 대장균 증식 억제 용도
WO2019039781A3 (ko) 신규한 에로모나스 살모니시다 박테리오파지 ａｅｒ-ｓａｐ-2 및 이의 에로모나스 살모니시다 균 증식 억제 용도
WO2019235783A8 (ko) 신규한 스트렙토코커스 수이스 박테리오파지 str-sup-3 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
WO2018117462A3 (ko) 신규한 비브리오 파라헤몰리티쿠스 박테리오파지 Ｖｉｂ-ＰＡＰ-4 및 이의 비브리오 파라헤몰리티쿠스 균 증식 억제 용도
WO2018236086A3 (ko) 신규한 에로모나스 하이드로필라 박테리오파지 Aer-HYP-2 및 이의 에로모나스 하이드로필라 균 증식 억제 용도
PH12017501943B1 (en) Influenza virus neutralizing peptidomimetic compounds
AR101538A1 (es) Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements